TY - JOUR
T1 - Targeting Viral Proteostasis Limits Influenza Virus, HIV, and Dengue Virus Infection
AU - Heaton, Nicholas S.
AU - Moshkina, Natasha
AU - Fenouil, Romain
AU - Gardner, Thomas J.
AU - Aguirre, Sebastian
AU - Shah, Priya S.
AU - Zhao, Nan
AU - Manganaro, Lara
AU - Hultquist, Judd F.
AU - Noel, Justine
AU - Sachs, David H.
AU - Hamilton, Jennifer
AU - Leon, Paul E.
AU - Chawdury, Amit
AU - Tripathi, Shashank
AU - Melegari, Camilla
AU - Campisi, Laura
AU - Hai, Rong
AU - Metreveli, Giorgi
AU - Gamarnik, Andrea V.
AU - García-Sastre, Adolfo
AU - Greenbaum, Benjamin
AU - Simon, Viviana
AU - Fernandez-Sesma, Ana
AU - Krogan, Nevan J.
AU - Mulder, Lubbertus C.F.
AU - van Bakel, Harm
AU - Tortorella, Domenico
AU - Taunton, Jack
AU - Palese, Peter
AU - Marazzi, Ivan
N1 - Publisher Copyright:
© 2016 Elsevier Inc.
PY - 2016/1/19
Y1 - 2016/1/19
N2 - Viruses are obligate parasites and thus require the machinery of the host cell to replicate. Inhibition of host factors co-opted during active infection is a strategy hosts use to suppress viral replication and a potential pan-antiviral therapy. To define the cellular proteins and processes required for a virus during infection is thus crucial to understanding the mechanisms of virally induced disease. In this report, we generated fully infectious tagged influenza viruses and used infection-based proteomics to identify pivotal arms of cellular signaling required for influenza virus growth and infectivity. Using mathematical modeling and genetic and pharmacologic approaches, we revealed that modulation of Sec61-mediated cotranslational translocation selectively impaired glycoprotein proteostasis of influenza as well as HIV and dengue viruses and led to inhibition of viral growth and infectivity. Thus, by studying virus-human protein-protein interactions in the context of active replication, we have identified targetable host factors for broad-spectrum antiviral therapies. Viruses are obligate parasites dependent on the host cell machinery. Using infection-based proteomics, biochemistry, and mathematical modeling, Marazzi and colleagues reveal that targeting host factors controlling essential cellular functions can provide broad-spectrum antiviral effects. Loss-of-function and chemical inhibition of one such factor, Sec61, inhibited influenza, HIV, and dengue virus replication.
AB - Viruses are obligate parasites and thus require the machinery of the host cell to replicate. Inhibition of host factors co-opted during active infection is a strategy hosts use to suppress viral replication and a potential pan-antiviral therapy. To define the cellular proteins and processes required for a virus during infection is thus crucial to understanding the mechanisms of virally induced disease. In this report, we generated fully infectious tagged influenza viruses and used infection-based proteomics to identify pivotal arms of cellular signaling required for influenza virus growth and infectivity. Using mathematical modeling and genetic and pharmacologic approaches, we revealed that modulation of Sec61-mediated cotranslational translocation selectively impaired glycoprotein proteostasis of influenza as well as HIV and dengue viruses and led to inhibition of viral growth and infectivity. Thus, by studying virus-human protein-protein interactions in the context of active replication, we have identified targetable host factors for broad-spectrum antiviral therapies. Viruses are obligate parasites dependent on the host cell machinery. Using infection-based proteomics, biochemistry, and mathematical modeling, Marazzi and colleagues reveal that targeting host factors controlling essential cellular functions can provide broad-spectrum antiviral effects. Loss-of-function and chemical inhibition of one such factor, Sec61, inhibited influenza, HIV, and dengue virus replication.
UR - http://www.scopus.com/inward/record.url?scp=84959065735&partnerID=8YFLogxK
U2 - 10.1016/j.immuni.2015.12.017
DO - 10.1016/j.immuni.2015.12.017
M3 - Article
C2 - 26789921
AN - SCOPUS:84959065735
SN - 1074-7613
VL - 44
SP - 46
EP - 58
JO - Immunity
JF - Immunity
IS - 1
ER -